Literature DB >> 33734316

A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis.

Shannon Teaw1, Monique Hinchcliff1, Michelle Cheng1.   

Abstract

As our understanding of the genetic underpinnings of SSc increases, questions regarding the environmental trigger(s) that induce and propagate SSc in the genetically predisposed individual emerge. The interplay between the environment, the immune system, and the microbial species that inhabit the patient's skin and gastrointestinal tract is a pathobiological frontier that is largely unexplored in SSc. The purpose of this review is to provide an overview of the methodologies, experimental study results and future roadmap for elucidating the relationship between the SSc host and his/her microbiome.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  faecal microbial transplant; microbial diversity; microbiome; microbiota; scleroderma; systemic sclerosis

Mesh:

Year:  2021        PMID: 33734316      PMCID: PMC8643452          DOI: 10.1093/rheumatology/keab262

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  84 in total

1.  Microbial and metabolic multi-omic correlations in systemic sclerosis patients.

Authors:  Chiara Bellocchi; Álvaro Fernández-Ochoa; Gaia Montanelli; Barbara Vigone; Alessandro Santaniello; Christian Milani; Rosa Quirantes-Piné; Isabel Borrás-Linares; Marco Ventura; Antonio Segura-Carrettero; Marta Eugenia Alarcón-Riquelme; Lorenzo Beretta
Journal:  Ann N Y Acad Sci       Date:  2018-05-11       Impact factor: 5.691

2.  Research Techniques Made Simple: Profiling the Skin Microbiota.

Authors:  Max D Grogan; Casey Bartow-McKenney; Laurice Flowers; Simon A B Knight; Aayushi Uberoi; Elizabeth A Grice
Journal:  J Invest Dermatol       Date:  2019-04       Impact factor: 8.551

3.  Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli.

Authors:  Jérôme Tourret; Benjamin P Willing; Sara Dion; Jayden MacPherson; Erick Denamur; Brett B Finlay
Journal:  Transplantation       Date:  2017-01       Impact factor: 4.939

Review 4.  The microbiome in autoimmune rheumatic disease.

Authors:  Maximilian F Konig
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-02-07       Impact factor: 4.098

5.  The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.

Authors:  Phillip L Molyneaux; Michael J Cox; Saffron A G Willis-Owen; Patrick Mallia; Kirsty E Russell; Anne-Marie Russell; Elissa Murphy; Sebastian L Johnston; David A Schwartz; Athol U Wells; William O C Cookson; Toby M Maher; Miriam F Moffatt
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 30.528

6.  Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin.

Authors:  Michael E Johnson; Jennifer M Franks; Guoshuai Cai; Bhaven K Mehta; Tammara A Wood; Kimberly Archambault; Patricia A Pioli; Robert W Simms; Nicole Orzechowski; Sarah Arron; Michael L Whitfield
Journal:  Arthritis Res Ther       Date:  2019-02-06       Impact factor: 5.606

7.  Sample storage conditions significantly influence faecal microbiome profiles.

Authors:  Jocelyn M Choo; Lex E X Leong; Geraint B Rogers
Journal:  Sci Rep       Date:  2015-11-17       Impact factor: 4.379

8.  Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts.

Authors:  Elizabeth R Volkmann; Anna-Maria Hoffmann-Vold; Yu-Ling Chang; Jonathan P Jacobs; Kirsten Tillisch; Emeran A Mayer; Philip J Clements; Johannes R Hov; Martin Kummen; Øyvind Midtvedt; Venu Lagishetty; Lin Chang; Jennifer S Labus; Øyvind Molberg; Jonathan Braun
Journal:  BMJ Open Gastroenterol       Date:  2017-04-01

9.  Screening FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification.

Authors:  Siew C Ng; Francis K L Chan; Paul K S Chan
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-04-22

10.  Host variables confound gut microbiota studies of human disease.

Authors:  Ivan Vujkovic-Cvijin; Jack Sklar; Lingjing Jiang; Loki Natarajan; Rob Knight; Yasmine Belkaid
Journal:  Nature       Date:  2020-11-04       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.